Generate a tailored SOP for Dr. Asier Unciti Broceta. Improve your application with a focused, well-structured draft.
Asier Unciti-Broceta is a Professor of Medicinal Chemistry at the University of Edinburgh, leading the Innovative Therapeutics Lab within the Institute of Genetics and Cancer. Since the establishment of his lab in 2010, Asier has focused on exploring novel chemical strategies to enhance the efficacy and safety of cancer treatments. His research includes the development of highly-selective kinase inhibitors that target cancer pathways, alongside innovative prodrug strategies designed to improve the clinical application of established chemotherapy drugs. Asier collaborates with various experts and institutes to drive forward his cancer research agenda, reflecting his commitment to advancing therapeutic options for cancer patients. His lab operates at the forefront of medicinal chemistry, integrating innovative methods with a robust understanding of cancer biology.
Department of Marketing